文献速递产科母胎医学

可溶性fms样酪氨酸激酶1与胎盘生长因子比值预测疑似子痫前期患者的分娩时间及分娩方式:INSPIRE试验的二次分析

The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia: a secondary analysis of the INSPIRE trial.
PubMed 文献 · Am J Obstet Gynecol · 2024-06-17

本研究为INSPIRE随机干预试验的二次分析,纳入疑似子痫前期孕妇,按可溶性fms样酪氨酸激酶1与胎盘生长因子比值分为≤38、>38且<85、≥85三组,发现比值越高分娩潜伏期越短、紧急剖宫产及产时胎儿窘迫风险越高,比值≥85对2周内子痫前期指征分娩有较高特异性。

要点

  • 比值≥85组分娩潜伏期中位数为10天,≤38组为37天,风险比为5.64。
  • 比值≥85组紧急剖宫产风险约为比值≤38组的5.89倍(OR 5.89)。
  • 比值≥85对2周内子痫前期指征分娩特异性92.7%、敏感性54.72%。

核心结论

  • 可溶性fms样酪氨酸激酶1与胎盘生长因子比值可能有助于对疑似子痫前期患者进行临床恶化、产时胎儿窘迫及分娩方式(包括产程中需干预)的风险分层。

研究设计与样本

  • INSPIRE随机干预试验的二次分析,纳入疑似子痫前期孕妇并检测可溶性fms样酪氨酸激酶1与胎盘生长因子比值。
  • 按比值分为3组:1组≤38;2组>38且<85;3组≥85。
  • 采用Kaplan-Meier曲线及Cox回归(校正采样时孕周和试验分组)分析比值至分娩时间,多因素logistic回归分析分娩方式等,多重线性回归分析出生体重z评分。

主要发现

  • 比值1-3组的分娩潜伏期中位数分别为37天、13天、10天,3组风险比为5.64(95%CI 4.06-7.84,P<.001)。
  • 比值≥85对2周内子痫前期指征分娩特异性为92.7%(95%CI 89.0%-95.1%),敏感性为54.72%(95%CI 41.3-69.5)。
  • 与比值≤38相比,3组自然阴道分娩几率降低(OR 0.47,95%CI 0.25-0.89),紧急剖宫产风险约为其5.89倍(OR 5.89,95%CI 3.05-11.21),产时胎儿窘迫需手术分娩或剖宫产风险约为其3.04倍(OR 3.04,95%CI 1.53-6.05)。
  • 与1组相比,2组和3组引产几率升高(2组OR 2.20,95%CI 1.02-4.76;3组OR 6.0,95%CI 2.01-17.93),且出生体重z评分中位数更低。
  • 在无子痫前期且自然临产亚组及子痫前期亚组中,因胎儿窘迫或产程停滞需干预者的log比值显著高于无干预阴道分娩者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor is a useful biomarker for preeclampsia. Since it is a measure of placental dysfunction, it could also be a predictor of clinical deterioration and fetal tolerance to intrapartum stress. OBJECTIVE: We tested the hypothesis that soluble fms-like tyrosine kinase 1 to placental growth factor ratio predicts time to delivery. Secondary objectives were to examine associations between the soluble fms-like tyrosine kinase 1 to placental growth factor ratio and mode of birth, fetal distress, need for labor induction, and birthweight z score. STUDY DESIGN: Secondary analysis of the INSPIRE trial, a randomized interventional study on prediction of preeclampsia/eclampsia in which women with suspected preeclampsia were recruited and their blood soluble fms-like tyrosine kinase 1 to placental growth factor ratio was assessed. We stratified participants into 3 groups according to the ratio result: category 1 (soluble fms-like tyrosine kinase 1 to placental growth factor ≤38); category 2 (soluble fms-like tyrosine kinase 1 to placental growth factor >38 and <85); and category 3 (soluble fms-like tyrosine kinase 1 to placental growth factor ≥85). We modeled time from soluble fms-like tyrosine kinase 1 to placental growth factor determination to delivery using Kaplan-Meier curves and compared the 3 ratio categories adjusting for gestational age at soluble fms-like tyrosine kinase 1 to placental growth factor determination and trial arm with Cox regression. The association between ratio category and mode of delivery, induction of labor, and fetal distress was assessed using a multivariable logistic regression adjusting for gestational age at sampling and trial arm. The association between birthweight z score and soluble fms-like tyrosine kinase 1 to placental growth factor ratio was evaluated using multiple linear regression. Subgroup analysis was conducted in women with no preeclampsia and spontaneous onset of labor; women with preeclampsia; and participants in the nonreveal arm. RESULTS: Higher ratio categories were associated with a shorter latency from soluble fms-like tyrosine kinase 1 to placental growth factor determination to delivery (37 vs 13 vs 10 days for ratios categories 1-3 respectively), hazards ratio for category 3 ratio of 5.64 (95% confidence interval 4.06-7.84, P<.001). A soluble fms-like tyrosine kinase 1 to placental growth factor ratio ≥85 had specificity of 92.7% (95% confidence interval 89.0%-95.1%) and sensitivity of 54.72% (95% confidence interval, 41.3-69.5) for prediction of preeclampsia indicated delivery within 2 weeks. A ratio category 3 was also associated with decreased odds of spontaneous vaginal delivery (Odds ratio [OR] 0.47, 95% confidence interval 0.25-0.89); an almost 6-fold increased risk of emergency cesarean section (OR 5.89, 95% confidence interval 3.05-11.21); and a 2-fold increased risk for intrapartum fetal distress requiring operative delivery or cesarean section (OR 3.04, 95% confidence interval 1.53-6.05) when compared to patients with ratios ≤38. Higher ratio categories were also associated with higher odds of induction of labor when compared to ratios category 1 (category 2, OR 2.20, 95% confidence interval 1.02-4.76; category 3, OR 6.0, 95% confidence interval 2.01-17.93); and lower median birthweight z score. Within subgroups of women a) without preeclampsia and with spontaneous onset of labor and b) women with preeclampsia, the log ratio was significantly higher in patients requiring intervention for fetal distress or failure to progress compared to those who delivered vaginaly without intervention. In the subset of women with no preeclampsia and spontaneous onset of labor, those who required intervention for fetal distress or failure to progress had a significantly higher log ratio than those who delivered vaginaly without needing intervention. CONCLUSION: The soluble fms-like tyrosine kinase 1 to placental growth factor ratio might be helpful in risk stratification of patients who present with suspected preeclampsia regarding clinical deterioration, intrapartum fetal distress, and mode of birth (including the need for intervention in labor).

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Palma Dos Reis CR, O'Sullivan J, Ohuma EO, et al. The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia: a secondary analysis of the INSPIRE trial. Am J Obstet Gynecol. 2024. PMID: 38897339. doi:10.1016/j.ajog.2024.06.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。